Search results for "Infectious diseases"
Guideline addresses viral testing in patients with community-acquired pneumonia
The new American Thoracic Society guideline opposes routine use of nucleic acid-based testing for noninfluenza viral pathogens in outpatients with community-acquired pneumonia but identifies some uses for the tests in inpatients.
https://immattersacp.org/weekly/archives/2021/05/11/4.htm
11 May 2021
Mixed findings on remdesivir for COVID-19, news on SARS-CoV-2 vaccines
Among other news this week, the NIH and the WHO released results from remdesivir trials, more negative findings were published for hydroxychloroquine, and ACP and Annals of Internal Medicine held a vaccine forum featuring Anthony S. Fauci, MD, MACP, and other experts.
https://immattersacp.org/weekly/archives/2020/10/20/2.htm
20 Oct 2020
Internal Medicine Meeting 2021: Virtual Experience to feature three plenary speakers, including Dr. Anthony Fauci
Join ACP for internal medicine's most comprehensive educational program in a new, engaging, interactive, and virtual format.
https://immattersacp.org/weekly/archives/2021/02/23/6.htm
23 Feb 2021
Studies look at COVID-19 vaccine boosters; ACP, Annals forum tackles challenging clinical questions
Two Israeli studies showed that vaccine boosters reduced rates of infection and severe disease. Experts gathered for the seventh ACP and Annals of Internal Medicine virtual forum on COVID-19. The FDA authorized a monoclonal antibody for pre-exposure prophylaxis in certain patients.
https://immattersacp.org/weekly/archives/2021/12/14/1.htm
14 Dec 2021
Interim data find vaccine 66% to 85% effective against symptomatic RSV in older adults
The results from a large ongoing phase 3 trial show success in protection from respiratory syncytial virus (RSV)-associated lower respiratory tract illness on two important primary endpoints, although reductions in hospitalization and death have yet to be shown.
https://immattersacp.org/weekly/archives/2023/04/11/1.htm
11 Apr 2023
Latest COVID-19 guidelines come out against bamlanivimab, remdesivir
The NIH and the Infectious Diseases Society of America found insufficient data to support bamlanivimab, while the World Health Organization said the same about remdesivir. The FDA issued more emergency use authorizations, and research looked at racial and other disparities in COVID-19 outcomes.
https://immattersacp.org/weekly/archives/2020/11/24/1.htm
24 Nov 2020
COVID-19 research covers taste and smell alterations, incidence in nursing homes and shelters, resource allocation policies
Other topics of note this week include guidance from the Infectious Diseases Society of America (IDSA) on personal protective equipment, plus information from the FDA and IDSA on serum antibody tests.
https://immattersacp.org/weekly/archives/2020/04/28/1.htm
28 Apr 2020
Latest research looks at prolonged symptoms, drug treatments in COVID-19
Two studies found symptoms to be common months to a year after COVID-19 infection, while other research found benefits from interleukin-6 inhibitors but no significant effects of ivermectin, remdesivir, and hydroxychloroquine.
https://immattersacp.org/weekly/archives/2021/07/13/1.htm
13 Jul 2021
DEI or DIE?
The College has become a leader in the world of justice, equity, diversity, and inclusion. While it is tempting to feel a sense of accomplishment, there is a gnawing feeling that more needs to be done.
https://immattersacp.org/archives/2021/05/dei-or-die.htm
1 May 2021
Answers and even more questions on COVID-19 vaccines
In a fourth forum from ACP and Annals of Internal Medicine, infectious disease experts Carlos del Rio, MD, FACP, Paul Sax, MD, and Deborah Cotton, MD, MPH, FACP, discussed COVID-19 vaccines and their implementation, as well as other aspects of the pandemic response.
https://immattersacp.org/weekly/archives/2021/03/30/2.htm
30 Mar 2021